Intercept Pharmaceuticals Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 2.18 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.22, with a Debt / Equity ratio of 3.12.
| Current Ratio | 4.22 |
| Quick Ratio | 3.92 |
| Debt / Equity | 3.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.56 |
| Interest Coverage | -5.39 |
Financial Efficiency
Return on equity (ROE) is -64.02% and return on invested capital (ROIC) is -9.27%.
| Return on Equity (ROE) | -64.02% |
| Return on Assets (ROA) | -7.23% |
| Return on Invested Capital (ROIC) | -9.27% |
| Return on Capital Employed (ROCE) | -18.22% |
| Revenue Per Employee | $931,625 |
| Profits Per Employee | -$180,680 |
| Employee Count | 341 |
| Asset Turnover | 0.67 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.02% in the last 52 weeks. The beta is 0.88, so ICPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +24.02% |
| 50-Day Moving Average | 15.98 |
| 200-Day Moving Average | 14.74 |
| Relative Strength Index (RSI) | 75.79 |
| Average Volume (20 Days) | 1,948,637 |
Short Selling Information
The latest short interest is 10.19 million, so 24.37% of the outstanding shares have been sold short.
| Short Interest | 10.19M |
| Short Previous Month | 9.43M |
| Short % of Shares Out | 24.37% |
| Short % of Float | 27.77% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ICPT had revenue of $317.68 million and -$61.61 million in losses. Loss per share was -$1.48.
| Revenue | 317.68M |
| Gross Profit | 317.05M |
| Operating Income | -55.10M |
| Pretax Income | -57.47M |
| Net Income | -61.61M |
| EBITDA | -54.72M |
| EBIT | -55.10M |
| Loss Per Share | -$1.48 |
Balance Sheet
The company has $322.71 million in cash and $223.86 million in debt, giving a net cash position of $98.86 million.
| Cash & Cash Equivalents | 322.71M |
| Total Debt | 223.86M |
| Net Cash | 98.86M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 71.85M |
| Book Value Per Share | 1.72 |
| Working Capital | 292.60M |
Cash Flow
In the last 12 months, operating cash flow was -$63.02 million and capital expenditures $186,000, giving a free cash flow of -$62.83 million.
| Operating Cash Flow | -63.02M |
| Capital Expenditures | 186,000 |
| Free Cash Flow | -62.83M |
| FCF Per Share | n/a |
Margins
Gross margin is 99.80%, with operating and profit margins of -17.34% and -19.39%.
| Gross Margin | 99.80% |
| Operating Margin | -17.34% |
| Pretax Margin | -18.09% |
| Profit Margin | -19.39% |
| EBITDA Margin | -17.22% |
| EBIT Margin | -17.34% |
| FCF Margin | n/a |
Dividends & Yields
ICPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.22% |
| Shareholder Yield | -35.22% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for ICPT is $22.50, which is 18.42% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.50 |
| Price Target Difference | 18.42% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 4.42% |
| EPS Growth Forecast (5Y) | -24.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ICPT has an Altman Z-Score of -5.42 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.42 |
| Piotroski F-Score | 3 |